Versor Investments’s Axonics, Inc. Common Stock AXNX Stock Holding History

Versor Investments’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-35,615	Closed	-$2.48M	–	1024
2024 Q3	$2.48M	Sell	35,615 -30,587	-46%	-$2.1M	0.39%	28
2024 Q2	$4.45M	Sell	66,202 -33,482	-34%	-$2.26M	0.82%	11
2024 Q1	$6.88M	Buy	+99,684	New	+$6.73M	1.39%	5
2023 Q3	–	Sell	-6,267	Closed	-$316K	–	865
2023 Q2	$316K	Sell	6,267 -4,252	-40%	-$226K	0.05%	394
2023 Q1	$574K	Buy	10,519 +1,442	+16%	+$84.2K	0.08%	276
2022 Q4	$568K	Buy	+9,077	New	+$602K	0.05%	303

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Versor Investments's AXNX Position: Q4 2024 in Review

Versor Investments sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 35,615 shares — an estimated $2.48M sold.

Versor Investments first reported a position in AXNX in Q4 2022 and held it in 6 quarters. The position peaked at $6.88M in Q1 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Versor Investments reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Versor Investments sold 35,615 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $2.48M.
Versor Investments first reported a position in Axonics, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
Versor Investments's Axonics, Inc. Common Stock position peaked at $6.88M in Q1 2024.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Versor Investments's 13F filing for Q4 2024, filed 5 Feb 2025.